Healthtech Startups

NutraMate provides AI-powered workflow automation for pharmacies, handling prescription fetching, processing, fulfillment, and review by cross-referencing pharmacy and formulary databases and integrating with existing Pharmacy Management Software. It targets pharmacies and pharmacy chains to reduce manual verification tasks and errors.

1 investor

NutriCal provides a cloud-based software platform for food safety compliance, nutrition analysis, and food labeling to food businesses in the GCC region. It serves restaurants, food manufacturers, meal plan companies, and retailers with features including calorie calculation, allergen tracking, recipe management, and regulatory compliance tools.

1 investor

NutriLeads employs in-house experts with backgrounds in food technology, microbiology, nutrition, and health across academic and industry sectors. The company appears to operate in the food and nutrition space with a focus on ingredient or food technology solutions.

1 investor

Nutrix develops digital health technology focused on hormonal intelligence and preventive health, including the cortiSense sensor and the gSense platform for cortisol monitoring and diabetes/obesity management. The company combines AI, nanotechnology, and medical expertise to shift care from treating illness toward preventive healthcare.

1 investor

Nuvaira develops the dNerva Lung Denervation System, a catheter-based device used in a one-time, outpatient bronchoscopic procedure that disrupts pulmonary nerve input to treat chronic obstructive pulmonary disease (COPD). The treatment targets COPD patients with lung hyperinflation and low emphysema, aiming to preserve lung function, reduce breathlessness, and lower exacerbations.

1 investor

NuVasive provides intraoperative neuromonitoring (IONM) services and implantable orthopedic and spinal devices for hospitals, surgeons, and patients, supported by board-certified neurologists and neurophysiologists. The company is transitioning its operations to Globus Medical.

1 investor

Nuvectis is a biopharmaceutical company developing oral small molecule therapies for cancer, including NXP900, an SRC Family Kinase inhibitor, and NXP800, a GCN2 activator being evaluated in solid tumors such as ovarian cancer and cholangiocarcinoma. Its drug candidates are in early-stage clinical trials for patients with advanced solid tumors.

1 investor

NuVision develops ocular biotherapies rooted in translational research from the University of Nottingham, aiming to provide patients with immediate access to innovative eye surface repair and regeneration treatments. The company operates across the UK, Middle East, Nordics, and central Europe.

1 investor

Nuvita provides virtual corporate wellness programs, including its "Better YOU" engagement challenges, to help organizations improve employee health behaviors and outcomes. It also offers a Corporate Wellness Accelerator with marketing programs for wellness professionals to build corporate wellness offerings in their local markets.

1 investor

NuvOx Pharma is a clinical-stage pharmaceutical company developing NanO₂, an oxygen therapeutic drug intended to improve oxygen delivery from lungs to blood and to tissue in order to reverse tissue hypoxia. Its clinical programs target indications including glioblastoma (as a radiosensitizer), stroke, and respiratory distress.

1 investor

NuXcel is a global medical device accelerator that founds and incubates bioelectronics and neuromodulation startups addressing large unmet clinical needs, using a lean innovation model. Operating with partner Treo Ventures, it has created companies such as ShiraTronics, Avivomed, iVEAcare, and iRiva Medical, with offices in Ireland, Minneapolis, and Silicon Valley.</parameter> <parameter name="founders">[{"full_name": "Mudit K. Jain", "title": "Founder and CEO"}, {"full_name": "Lynn Elliott", "title": "Founder and CTO"}]</parameter> <parameter name="hq_city">Minneapolis

1 investor

Nuxera develops AI solutions for healthcare applications focused on the Saudi Arabian and MENA region market.

1 investor

NVA is a veterinary care network operating through community hospitals, specialty and emergency clinics, pet resorts, and equine practices to deliver comprehensive pet healthcare and related services.

1 investor

nView medical develops the nView s1, a low-dose 3D imaging and surgical navigation system with true-map navigation and AI-based intraoperative planning, guidance, and quality control. The system is designed for pediatric and adult surgery, used by children's hospitals and surgical teams.

1 investor

CoachCare provides a remote care platform and US-based clinical care management team that helps medical practices run remote patient monitoring, chronic care management, and other Medicare, Medicaid, commercial, and value-based care programs. It offers a unified care management interface, connected monitoring devices, patient apps, and bi-directional EHR integrations for healthcare organizations.

1 investor

Nykode Therapeutics is a biotechnology company; this investor relations page provides shareholder information, financial reports, and corporate governance details but does not describe the company's specific products or therapeutic focus.

1 investor

Nymbl Systems provides a cloud-based software platform for managing patient intake, claims processing, scheduling, and inventory operations for healthcare organizations.

1 investor

NyquistAI provides an AI-powered intelligence platform that aggregates clinical and regulatory documentation into searchable information and insights for life science companies. It operates in the health technology and life sciences data space.

1 investor

Nyra Health offers myReha, a CE-certified digital therapy system with over 65,000 exercises for neurological rehabilitation covering speech (aphasia), memory, attention and other cognitive functions, used in speech therapy, occupational therapy and neuropsychology. It serves patients, clinics and therapy practices in Germany, with treatment costs covered by public and private health insurers.

1 investor

Sagent Behavioral Health is one of the largest behavioral health organizations in the country, serving over 100,000 patients annually across five states through therapy, psychiatry, substance use treatment, and psychological services for adults, children, couples, and families.

1 investor

Nyxoah is a medical device manufacturer focused on product security and vulnerability disclosure procedures for its healthcare devices and services. The page outlines the company's responsible disclosure policy for security researchers to report vulnerabilities affecting patients, caregivers, operators, and customers.

1 investor

New Zealand Health Group is a community health and disability support provider serving over 30,000 people across New Zealand through in-home care, aged care, disability services, mental health support, and employee wellbeing programs. The organization operates as the country's largest community health group, employing over 10,000 staff and partnering with government agencies and community organizations.

1 investor

Dimericon Therapeutics is a biotech company developing crosslinked helix dimers ("Dimericons") as therapeutics and as templates for small-molecule development, targeting hard-to-drug intracellular protein-protein interactions. Its lead program focuses on hematological malignancies, with a seed round supporting preclinical work toward an IND-ready clinical candidate.

1 investor

O2X provides an integrated readiness platform combining personnel development, advanced reporting, and technology services for organizations. It delivers consulting, in-person training, embedded specialists, and a suite of performance tools designed for federal agencies, military, corporate clients, sports organizations, and law enforcement.

1 investor